Skip to main content
Part of Sickle Cell Disease on Somebody To Talk To
Loading page…
Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study (2017 archive) | oneSCDvoice